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ABSTRACT 
A straightforward chemoenzymatic synthesis of (S)-Pindolol has been developed. The 
key step involved the enzymatic kinetic resolution of rac-2-acetoxy-1-(1H-indol-4-
yloxy)-3-chloropropane with lipase from Pseudomonas fluorescens via hydrolytic 
process to obtain enantiomerically enriched halohydrin (2S)-1-(1H-indol-4-yloxy)-3-
chloro-2-propanol (96% ee) and (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane 
(97% ee). The latter was subjected to a hydrolysis reaction catalyzed by Candida 
rugosa leading to (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (97% ee), followed 
by a reaction with isopropylamine, producing (S)-Pindol (97% ee) in quantitative yield.  
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Pindolol, 1-(1H-indol-4-yloxy)-3-(isopropylamino)-2-propanol (Fig. 1), is a 
pharmaceutically active substance, commercially marketed under the brand name 
Visken (Sandoz) or Barbloc (Alpha) [1]. It is noteworthy that (S)-Pindolol (S-5) is 200 
times more active than (R)-Pindolol [2]. This drug is a nonselective β-blocker, which 
has a higher intrinsic sympathomimetic activity as compared to any currently available 
β-blocker, acting effectively as antianginal, antihypertensive, and antiarrhythmic [3]; 
interestingly, Pindolol is also used in the treatment of glaucoma [4]. It is an effective 
agent for the treatment of hypertension in pregnancy, since it has no effects on fetal 
haemodynamics and does not affect fetal cardiac function [5]. Beside these established 
uses, (S)-Pindolol can be used in combination with antidepressants selective inhibitors 
of serotonin reuptake (SSRI), overcoming the action of these drugs [6,7]. Although an 
old-fashioned drug, new applications have been reported for the (S)-Pindolol, such as in 
the treatment of fibromyalgia and related fatigue syndromes [8], premenstrual syndrome 
and premenstrual dysphoric disorder [9], as well as aiding in the treatment of cachexia 
and sarcopenia [10]. 
Biocatalysis offers an alternative approach to conventional chemical processes for the 
production of single-isomer chiral drugs. Lipases are highlighted as being among the 
most frequently used enzymes for the production of drugs and their intermediates [11-
14]. The use of lipases is mainly due to the characteristics of the regio-, chemo- and 
enantioselectivity in the resolution process of racemates, without the use of cofactors. 
Moreover, this class of enzymes has generally excellent stability in the presence of 
organic solvents, facilitating the solubility of the organic substrate to be modified [14]. 
The chemoenzymatic synthesis of β-blockers such as propranolol, toliprol, moprolol, 
alprenolol, penbutenol, atenolol, practolol, oxprenolol, acebutolol, sotalol and nifenalol 
is a well-documented subject in the literature [15-27]. 
Many reports regarding the synthesis of (S)-Pindolol include the preparation of chiral 
intermediates via lipase-mediated kinetic resolution as a key step. An example is the 
hydrolysis of rac-1,2-diacetoxy-3-chloropropane, in the presence of lipoprotein lipase, 
leading to (S)-1,2-diacetoxy-3-chloropropane which was converted to (S)-3-(4-
indolyloxy)-1,2-propanediol (90% ee and 20% yield). In this case, the authors stated 
that this latter chiral intermediate can be used in the synthesis of (S)-Pindolol [28]. 
Another example is the hydrolysis of rac-1-acetoxy-2,3-dichloropropane in the presence 
of pancreatin to give (S)-1-acetoxy-2,3-dichloropropane (90% ee). The latter was 
reacted with 4-hydroxyindole in basic medium, yielding the crude (S)-Pindolol in 45% 
yield. After a benzene treatment, the (S)-Pindolol was recovered in 31% yield [[α]D25 = - 
2.52 (c 1.0, MeOH)]. Finally, after recrystallization from benzene, the (S)-Pindolol was 
obtained in 12% yield [[α]D25 = - 3.4 (c 5.9, MeOH)] [29]. Enantiomerically pure (S)-
Pindolol was prepared from (R)-3-chloro-1,2-propanediol in 65% yield [30,31] as well 
as from (S)-glycidyl nosylate in 83% yield [32], but the authors did not report how these 
intermediates were obtained. Another synthesis of (S)-Pindolol (88% yield and 92% ee) 
include a catalytic asymmetric nitroaldol reaction using Lanthanum-Lithium-(R)-
BINOL, (R)-LLB, as chiral catalyst [33]. 
In general, a major drawback in the use of epichlorohydrin or glycidyl esters as chiral 
intermediates in the preparation of β-blockers is a competition between substitution at 
C-1 and ring-opening at C-3 during the nucleophilic attack of the anion aryloxy, leading 
to a decrease in the optical purity of the final product [1,30,34]. An effective approach 
to circumvent this problem is the enzymatic kinetic resolution of chlorohydrins, rac-1-
aryloxy-3-chloro-2-propanol, to obtain the corresponding chiral compound to be used as 
intermediate. This approach has been applied in the synthesis of a series of (S)-β-
blockers as propranolol, toliprol, moprolol, alprenolol, penbutenol, atenolol, practolol 
and oxprenolol. In this case, two complementary methods were used, the hydrolysis of 
rac-2-acetoxy-1-aryloxy-3-chloropropane and acetylation of rac-1-aryloxy-3-chloro-2-
propanol using vinyl acetate as acyl donor and tert-butyl methyl ether (TBME) as 
solvent, both methods in the presence of lipase from Pseudomonas sp. [15]. More 
recently, CAL-A (CLEA) [25] and CAL-B [27] mediated the kinetic resolution of 
halohydrins, precursors of the β-blocker Atenolol, with E values > 200. It is noteworthy 
that various optically pure aromatic chlorohydrins were prepared via dynamic kinetic 
resolution (DKR) with the use of lipase from Pseudomonas cepacia (PS-C “Amano” II) 
combined with an efficient racemization with Ru complex catalyst [35]. 
To the best of our knowledge, there are no reports relating to the preparation of chiral 
halohydrin 1-(1H-indol-4-yloxy)-3-chloro-2-propanol from lipase-mediated kinetic 
resolution to be used as an intermediate for the synthesis of (S)-Pindolol.  
Herein, we wish to report the chemoenzymatic synthesis of (S)-Pindolol (S-5) in which 
the key step was the preparation of (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-
3) (Fig. 1) as intermediate, in the presence of lipases. We have focused especially on the 
optimization of the reactional conditions.  
 
2. Experimental 
2.1. Enzymes  
(i) Immobilized lipases: C. antarctica lipase type B immobilized on acrylic resin 
(CAL-B, Novozym 435, 7,300.0 U/g) and R. miehei lipase immobilized on anionic resin 
(RML, 150.0 U/g) were purchased from Novozymes®. T. lanuginosus lipase 
immobilized on immobead-150 (TLL, 250.0 U/g), R. oryzae lipase immobilized on 
immobead-150 (ROL, 340.0 U/g) and Amano lipase PS from B. cepacia immobilized 
on diatomaceous earth (PS-IM, ≥ 500 U/g) were acquired from Sigma-Aldrich® (ii) 
Crude lipase preparations: P. fluorescens lipase (AK, 22,100.0 U/g), P. camemberti 
lipase (G, 50.0 U/g), A. melleus lipase (Acylase I, 200.0 U/g), Amano lipase PS from B. 
cepacia (PS, ≥ 30,000U/g), lipase from R. niveus (RNL, ≥ 1.5 U/mg), Amano lipase 
from M. javanicous (MJL, ≥ 10,000 U/g) and lipase from A. niger (ANL, 200 U/g) were 
acquired from Sigma-Aldrich®. Porcine pancreas lipase (PPL, 46.0 U/g solid), and C. 
rugosa lipase (CRL, 1.4 U/g) were obtained from Sigma®. 
2.2. Chemical materials 
Chemical reagents were purchased from different commercial sources and used 
without further purification. Acetone, hexane and dichloromethane were acquired from 
Synth®. Toluene was obtained from Dinamica® and dioxane from Carlo Erba®. 
Isopropanol (IPA), acetonitrile and hexane, HPLC grade, were purchased from 
TEDIA®. Tetrahydrofuran (THF), heptane, cyclohexane and tert-butylmethylether 
(TBME) were acquired from Sigma-Aldrich®. Solvents used in the reaction of 
biocatalysis were distilled over an adequate desiccant under nitrogen. Analytical TLC 
analyses were performed on aluminum sheets pre-coated with silica gel 60 F254 (0.2 
mm thick) from Merck®. Flash chromatographies were performed using silica gel 60 
(230-240 mesh). 
2.3. Analysis 
Melting points of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4) and 
(S)-Pindolol (S-5) were determined in open capillary tube Mettler Toledo model FP62 
and are uncorrected. IR spectra were recorded on a Perkin - Elmer 1720-X F7 using 
NaCl plates or KBr in pellets. 1H and 13C NMR were obtained using Spectrometer 
Bruker model Avance DRX-500, operating at frequency of 500 MHz for hydrogen and 
frequency of 125 MHz for carbon. The chemical shifts are given in delta (δ) values and 
the absolute values of coupling constants (J) in Hertz (Hz). Measurement of the optical 
rotation was done in a Perkin-Elmer 241 polarimeter. High performance liquid 
chromatography (HPLC) analyses were carried out in a Shimadzu chromatograph model 
LC solution 20A using a chiral column Chiracel® OD-H (150 m x 4.6 mm I.D.) with 
oven set at 35 °C . For the following of the reaction time courses: Flow was 1.0 mL/min 
using hexane:IPA (80:20) as eluent and UV detector at 265 nm. Retention times were: 
(S)-acetate (S-4) 7.8 min; (R)-acetate (R-4) 8.8 min; (S)-alcohol (S-3) 10.9 min; (R)-
alcohol (R-3) 25.1 min. 
2.4 Calculation of enantiomeric excess, conversion and enantioselectivity 
The efficiency of the kinetic resolution was evaluated based on the optical purity of 
the compounds, expressed in terms of enantiomeric excess of the substrate (e.e.s) and 
product (e.e.p), using the following Eq. (1) and (2): 





e.e.p =                                                                                                        (2)       
X denote the major enantiomer and Y denote the minor enantiomer represented by their 
chromatographic peak areas. 
The conversion (c) is calculated using Eq. (3): 
c =                                                                                                      (3) 
Enantioselectivity was expressed as enantiomeric ratio (E) and calculated by Eq. (4): 
E =                                                                                            (4)   
 The results of the e.e.s and e.e.p are expressed in percentage using the Eq. (5) and  
(6): 
e.e.s =  x 100                                                                                             (5)   
e.e.p =  x 100                                                                                            (6)   
Additionally, the conversion (c) is also calculated in percentage, using (5) and (6).                                                                                                                   
2.5. Synthesis of rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) 
To a suspension of 500 mg (3.75 mmol) of 4-hydroxyindole (1) in 5 mL of aqueous 
solution of sodium hydroxide (NaOH 0.75 M), 2.5 mL (32 mmol) of (±)-
epichlorohydrin in 2 mL of dioxane was added. The reaction was stirred for 6 h at room 
temperature under N2. The progress of the reaction was monitored by thin layer 




























evaporated under reduced pressure. The crude product was purified by flash 
chromatography on silica gel using dichloromethane as eluent, yielding rac-1-(1H-
indol-4-yloxy)-3-chloro-2-propanol (rac-3) (66% yield) and (1H-indol-4-yloxy)(2-
oxiranyl)methane (rac-2) (22% yield). This latter was converted to rac-1-(1H-indol-4-
yloxy)-3-chloro-2-propanol (rac-3) as follows: to a solution of 152.4 mg (0.81 mmol) of 
(1H-indol-4-yloxy)(2-oxiranyl)methane (rac-2)  in 5 mL of dichloromethane, 5 mL of 
concentrated HCl was added. The reaction mixture was stirred for 1 hour. Then, the 
product was extracted with dichloromethane (3 x 5 mL) and dried with anhydrous  
Na2SO4. After filtration, the solvent was evaporated under reduced pressure. The crude 
product was purified by chromatography using silica gel and dichloromethane as eluent. 
Finally, the rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) was obtained with an 
overall yield of 85% (718.8 mg). 
2.6.  Synthesis of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4) 
DMAP (22 mg, 0.19 mmol) and acetic anhydride (360 µL, 3.8 mmol) were added to 
a rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) (50 mg, 0.38 mmol) solution in 
dichloromethane (4.0 mL). The reaction was stirred at room temperature during 1 h and 
after that time, the solvent was evaporated under reduced pressure. The resulting crude 
product was purified by flash chromatography on silica gel , using dichloromethane as 
eluent, to afford the desired rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-
4) as a yellow liquid in 93% yield (94.5 mg). 
2.7. Synthesis of (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3) via hydrolysis 
A suspension of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4)  (5 
mg, 0.019 mmol) and 10 mg of lipase from Pseudomonas fluorescens in a mixture of 
152 µL of phosphate buffer 100 mM (pH 7.0) and 38 µL of THF (80/20 v/v) was shaken 
at 40 °C and 250 rpm for 25 h. After this time, the products were extracted with EtOAc 
(3 x 1.0 mL) and the organic phases were combined and dried with anhydrous Na2SO4, 
filtered and the solvent evaporated under reduced pressure. The crude product was 
purified by flash chromatography on silica gel using dichloromethane as eluent, 
yielding 2 mg of (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (R-4) (40.5% 
% yield and 97% ee) and 2 mg of (2S)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (S-3) 
(46.7% yield and 96% ee). Then, a suspension of (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-
3-chloropropane (R-4)  (5 mg, 0.019 mmol) and 5 mg of lipase from Candida rugosa 
(ratio 1:1 in weight respect to the R-4) in a mixture of 152 µL of phosphate buffer 100 
mM (pH 7.0) and 38 µL of THF (80/20 v/v) was shaken at 40 °C, 250 rpm for 12 h. 
After this time, the reaction mixture was centrifuged, the supernatant was removed and 
the product was extracted with EtOAc (3 x 1.0 mL). The organic phases were combined 
and dried with anhydrous Na2SO4, filtered and the solvent evaporated under reduced 
pressure, yielding 4.3 mg of (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3) 
(100% yield, [α]D20 = + 2.19 (c 0.9, CHCl3) for 97% e.e. of the (R)-enantiomer). 
2.8. Synthesis of (S)-Pindolol (S-5) 
 A solution of (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3) (100 mg, 0.44 
mmol) in excess of isopropylamine (4 mL) was stirred under reflux for 12 h. After this 
time, the excess of amine was evaporated under reduced pressure and the product was 
extracted with EtOAc (3 x 1.0 mL). The solvent was evaporated under reduced pressure, 
yielding 109.5 mg of (S)-Pindolol (S-5) as a white solid in quantitative yield, ([α]D20 = - 
4.1 (c 0.62, MeOH) for 97% e.e. of the (S)-enantiomer. Lit [α]D20 = - 3.8 (c 0.62, 
MeOH) for 92% e.e. of the (S)-enantiomer) [33]. 
2.9. General procedure for the lipase-catalyzed hydrolysis of rac-2-acetoxy-1-(1H-
indol-4-yloxy)-3-chloropropane (rac-4) (screening) Table 1 
A suspension of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane rac-4 (5 mg, 
0.019 mmol), 5 mg of lipase (ratio 1:1 in weight respect to the rac-4) in a mixture of 
152 µL of phosphate buffer 100 mM (pH 7.0) and 38 µL of THF (80/20 v/v) was shaken 
at 30 °C, 250 rpm for varied times (ranging from 12 to 36 h). After each period, the 
products were extracted with EtOAc (3 x 1.0 mL) and the organic phases were 
combined and dried with anhydrous Na2SO4, filtered and the solvent evaporated under 
reduced pressure. The crude product was purified by flash chromatography on silica gel 
using dichloromethane as eluent, yielding (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (R-4) and (2S)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (S-3). Their 
enantiomeric excess were determined by HPLC. 
2.10. General procedure for the lipase-catalyzed acetylation of rac-1-(1H-indol-4-
yloxy)-3-chloro-2-propanol (rac-3) Table 3 
To a suspension of the rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) (4 mg, 
0.018 mmol) and lipase (4 mg) in dry organic solvent (0.18 µL) under nitrogen 
atmosphere, vinyl acetate (7.8 µL, 0.085 mmol) was added, and the reaction was shaken 
(250 rpm) at temperatures ranging from 30 °C to 40 °C. Aliquots were regularly 
analyzed by HPLC and after the adequate time, the reaction was stopped and the 
enzyme filtered off and washed with the respective solvent (3 mL). The solvent was 
evaporated under reduced pressure and the crude products purified by flash 
chromatography on silica gel using dichloromethane as eluent. This procedure yielded 
(2S)-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (S-4) and (2R)-1-(1H-indol-4-
yloxy)-3-chloro-2-propanol (R-3), being their enantiomeric excess determined by 
HPLC. 
rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3): Oil. Rf (100% CH2Cl2): 0.30. 
IR umax (cm1): 3403, 2924, 1616, 1585, 1502, 1440, 1241, 1087 and 736 cm-1. 1H NMR 
(500 MHz, CD3OD) δ (ppm): 2.66 (br s, 1H), 3.8 (dd, 1H, J=11.2 Hz and 5.6 Hz), 3.9 
(dd, 1H, J= 11.2 Hz and 5.0 Hz), 4.2-4.3 (m, 3H), 6.6 (d, 1H, J= 7.6 Hz), 6.7 (m, 1H), 
7.1-7.2 (m, 3H) and 8.2 (br s, 1H).13C NMR (125 MHz, CD3OD) δ (ppm): 46.4 (CH2), 
68.9 (CH2), 70.2 (CH), 99.9 (CH), 101.2 (CH), 105.4 (CH), 118.9(C), 122.9 (CH), 
123.2 (CH), 137.6 (C) and 152.1 (C). 
rac-(1H-indol-4-yloxy)(2-oxiranyl)methane (rac-2): Oil. Rf (100% CH2Cl2): 0.57. IR 
umax (cm-1): 3401, 1361, 1240 and 1086 cm-1. 1H NMR (500 MHz, CDCl3) δ (ppm): 2.8 
(dd, 1H, J= 5.0 Hz and 2.6 Hz), 2.9 (m, 1H), 3.4-3.5 (m, 1H), 4.2 (dd, 1H, J= 11.1 Hz 
and 5.5 Hz), 4.4 (dd, 1H, J= 11.1 Hz and 3.2 Hz), 6.5 (d, 1H, J= 7.6 Hz), 6.7 (m, 1H), 
7.0-7.1 (m, 3H) and 8.2 (br s, 1H). 13C NMR (125 MHz, CDCl3) δ (ppm): 45.1 (CH2), 
50.6 (CH), 69.0 (CH2), 100.2 (CH), 101.1 (CH), 105.2 (CH), 119.0 (C), 122.9 (CH), 
123.0 (CH), 137.6 (C) and 152.4 (C). 
rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4): Solid. Mp: 101-106 
°C. Rf (100% CH2Cl2): 0.65. IR umax (cm-1): 3409, 1736, 1224, and 1047 cm-1. 1H NMR 
(500 MHz, CDCl3) δ (ppm): 2.1 (s, 3H), 3.8 (dd, 1H, J= 11.7 Hz and 5.5 Hz), 3.9 (dd, 
1H, J= 11.7 Hz and 4.8 Hz), 4.3 (m, 2H), 5.4-5.5 (m, 1H), 6.5 (d, 1H, J= 7.6 Hz), 6.7 
(m, 1H), 7.0-7.1 (m, 3H), and 8.2 (br s, 1H). 13C NMR (125 MHz, CDCl3) δ (ppm): 21.1 
(CH3), 43.0 (CH2), 66.5 (CH2), 71.5 (CH), 100.0 (CH), 101.2 (CH), 105.4 (CH), 119.0 
(C), 122.9 (CH), 123.1 (CH), 137.6 (C), 152.1 (C) and 170.5 (C).  
(S)-Pindolol (S-5): Solid. Mp: 168-170 °C. IR umax (cm-1): 3303, 2964, 1242, 1086, 
and 879 cm-1. 1H NMR (500 MHz, CD3OD) δ (ppm): 1.12 (d, 3H, J= 5.4 Hz), 1.13 (d, 
3H, J= 5.2 Hz), 2.7-2.8 (m, 1H), 2.9-3.0 (m, 2H), 4.0-4.2 (m, 3H), 6.5 (dd, 1H, J= 6.7 
Hz and 1.4 Hz), 6.53-6.54 (m, 1H), 7.0-7.1 (m, 3H). 13C NMR (125 MHz, CD3OD) δ 
(ppm): 22.3 (CH3), 22.4 (CH3), 50.1 (CH), 51.1 (CH2), 69.8 (CH), 72.0 (CH2), 99.7 
(CH), 101.3 (CH), 106.3 (CH), 120.2 (C), 123.1 (CH), 124.2 (CH), 139.3 (C) and 153.6 
(C). [α]D20 = - 4.1 (c 0.62, MeOH) for 97% e.e. of the (S)-enantiomer. Lit [α]D20 = - 3.8 
(c 0.62, MeOH) for 92% e.e. of the (S)-enantiomer [33]. 
3. Results and Discussion 
The chemoenzymatic route for the production of (S)-Pindolol (S-5) is depicted in 
Fig. 1. The key step involved the preparation of the enantiomerically enriched 
halohydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3) via kinetic resolution 
in the presence of a lipase. 
 
2,3-dichloropropane in the presence of pancreatin to give (S)-1-
acetoxy-2,3-dichloropropane (90% ee). The latter was reacted with
4-hydroxyindole in basic medium, yielding the crude (S)-Pindolol in
45% yield. After treatment with benzene, the (S)-Pindolol was re-
covered in 31% yield [[α]D25 =− 2.52 (c 1.0, MeOH)]. After re-
crystallization, the (S)-Pindolol was obtained in 12% yield
[[α]D25 =−3.4 (c 5.9, MeOH)] [29]. The syntheses of en-
antiomerically pure (S)-Pindolol was also reported from (R)-3-
chloro-1,2-propanediol in 65% yield [30,31] as well as from (S)-
glycidyl nosylate in 83% yield [32], but the authors did not informed
how these intermediates were obtained. Another example of synth-
esis of (S)-Pindolol (88% yield and 92% ee) include a catalytic
asymmetric nitroaldol reaction using Lanthanum-Lithium-(R)-
BINOL, (R)-LLB, as chiral catalyst [33].
In general, a major drawback in the use of epichlorohydrin or gly-
cidyl esters as chiral intermediates in the preparation of β-blockers is a
competition between substitution at C-1 and ring-opening at C-3 during
the nucleophilic attack of the anion aryloxy, leading to a decrease in the
optical purity of the ﬁnal product [1,30,34]. An eﬀective approach to
circumvent this problem is the enzymatic kinetic resolution of chlor-
ohydrins, rac-1-aryloxy-3-chloro-2-propanol, to obtain the corre-
sponding chiral compound to be used as intermediate. This approach
has been applied in the synthesis of a series of (S)-β-blockers as pro-
pranolol, toliprol, moprolol, alprenolol, penbutenol, atenolol, practolol
and oxprenolol. In this case, two complementary methods were used,
the hydrolysis of rac-2-acetoxy-1-aryloxy-3-chloropropane and acet-
ylation of rac-1-aryloxy-3-chloro-2-propanol using vinyl acetate as acyl
donor and tert-butyl methyl ether (TBME) as solvent, both methods in
the presence of lipase from Pseudomonas sp. [15]. More recently, CAL-A
(CLEA) [25] and CAL-B [27] mediated the kinetic resolution of halo-
hydrins, precursors of the β-blocker Atenolol, with E values> 200. It is
noteworthy that various optically pure aromatic chlorohydrins were
prepared via dynamic kinetic resolution (DKR) with the use of lipase
from Pseudomonas cepacia (PS-C “Amano” II) combined with an eﬃcient
racemization with Ru complex catalyst [35].
To the best of our knowledge, there are no reports relating to the
preparation of chiral halohydrin 1-(1H-indol-4-yloxy)-3-chloro-2-pro-
panol from lipase-mediated kinetic resolution to be used as an inter-
mediate for the synthesis of (S)-Pindolol.
Herein, we wish to report the chemoenzymatic synthesis of (S)-
Pindolol (S-5) in which the key step was the preparation of (2R)-1-(1H-
indol-4-yloxy)-3-chloro-2-propanol (R-3) (Fig. 1) as intermediate, in
the presence of lipases. We have focused especially on the optimization
of the reactional conditions.
2. Experimental
2.1. Enzymes
(i) Immobilized lipases: Candida antarctica lipase type B im-
mobilized on acrylic resin (CAL-B, Novozym 435, 7,300.0 U/g) and
Rhizomucor miehei lipase immobilized on anionic resin (RML,
150.0 U/g) were purchased from Novozymes®. Thermomyces lanugi-
nosus lipase immobilized on immobead-150 (TLL, 250.0 U/g),
Rhizopus oryzae lipase immobilized on immobead-150 (ROL,
340.0 U/g) and Amano lipase PS from Burkholderia cepacia im-
mobilized on diatomaceous earth (PS-IM, ≥500 U/g) were acquired
from Sigma-Aldrich® (ii) Crude lipase preparations: Pseudomonas
ﬂuorescens lipase (AK, 22,100.0 U/g), Penicillium camemberti lipase
(G, 50.0 U/g), Amano lipase PS from B. cepacia (PS, ≥ 30,000U/g),
lipase from Rhizopus niveus (RNL, ≥ 1.5 U/mg), Amano lipase from
Mucor javanicus (MJL,≥10,000 U/g) and lipase from Aspergillus niger
(ANL, 200 U/g) were acquired from Sigma-Aldrich®. Porcine pan-
creas lipase (PPL, 46.0 U/g solid), and C. rugosa lipase (CRL, 1.4 U/g)
were obtained from Sigma®.
Fig. 1. Chemoenzymatic synthesis of (S)-Pindolol.
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3.1. Synthesis of halohydrin rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) and 
its acetate (rac-4) 
Initially, the halohydrin rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) was 
obtained from the reaction between the commercially available reagents 4-
hydroxyindole (1) and epichlorohydrin. In this case, beyond the expected halohydrin, 
rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) (66% yield), the epoxide rac-
(1H-indol-4-yloxy)(2-oxiranyl)methane (rac-2) (22% yield) was obtained. Then, the 
epoxide was converted to the desired halohydrin after treatment with concentrated HCl. 
Thus, it was possible to obtain the rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-
3) with global yield of 85%. Subsequently, by the use of acetic anhydride and 4-
dimethylaminopyridine (DMAP), the corresponding acetate rac-2-acetoxy-1-(1H-indol-
4-yloxy)-3-chloropropane (rac-4) was prepared with 93% yield. Both compounds, rac-3 
and rac-4, were analyzed by chiral HPLC to find the adequate conditions for the 
separation of their enantiomers (Fig. 2). 
INSERT FIGURE 2 A and 2 B HERE 
Fig. 2. A) HPLC chromatograms of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (rac-4: (S) tR 19.1 min.; (R) tR 20.9 min.)  
Fig. 2 B) rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3: (S) tR 27.7 min.; (R) tR 
34.0 min.). 
3.2. Kinetic resolution of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4) 
via hydrolysis reaction 
Initially, thirteen commercially available lipases were evaluated in the kinetic resolution 
of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4) via hydrolysis reaction, 
Fig. 3 (Path a). The reactions were conducted at 30 °C, using 1:1 ratio (w:w) of 
substrate/lipase, phosphate buffer (pH 7.0) and THF as a co-solvent (buffer/co-solvent 
4:1, v:v). The reactions were monitored by chiral HPLC and stopped within 12-36 h, 
when the conversions reached values close to 50%. The experimental data are 
summarized in Table 1. 
INSERT FIGURE 3 HERE 
Fig. 3. (Path a) Enzymatic kinetic resolution of rac-4 via hydrolysis reaction. (Path b) 
Enzymatic kinetic resolution of rac-3 via acetylation reaction. 
Table 1. Kinetic resolution via hydrolysis of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (rac-4) using lipases.a      









1 P. camemberti 24 - - 0 - 
2 R. oryzae immobilized on 
immobead-150 
24 - - 0 - 
3 Porcine pancreas 24 - - 0 - 
4 R. miehei immobilized on anionic 
resin 
24 - - 0 - 
5 R. niveus 24 - - 0 - 
6 Amano lipase from M. javanicous 24 - - 0 - 
7 P. fluorescens 36 81 87 48 36 
8e P. fluorescens 23 90 94 49 100 
9f P. fluorescens 25 97 96 50 207 
10 T. lanuginosus immobilized on 
immobead-150 
36 80 94 46 79 
11e T. lanuginosus immobilized on 
immobead-150 
33 87 93 48 78 
12f T. lanuginosus immobilized on 
immobead-150 
24 81 89 48 43 
13 Novozym 435 12 91 81 53 30 
14 C. rugosa 20 37 54 41 5 
15 Amano lipase PS from B. cepacia 
immobilized on diatomaceous 
earth 
12 63 78 45 15 
16 Amano lipase PS from B. cepacia 12 55 63 47 8 
17 A. niger g 24 54 64 46 8 
       
a Conditions: 30 ºC, lipase:rac-4 (1:1) at 250 r.p.m. 
b Determined by HPLC. 
c Conversion, c = e.e.s/(e.e.s+e.e.p). 
d Enantiomeric ratio, E = ln[1-c(1+e.e.p)]/ln[1-c(1-e.e.p)] 
e Conditions: 40 ºC, lipase:rac-4 (1:1) at 250 r.p.m. 
f Conditions: 40 ºC, lipase:rac-4 (2:1) at 250 r.p.m. 
g Inverse configurations 
  
Lipases from P. camemberti, R. oryzae immobilized on immobead-150, porcine 
pancreas, R. miehei immobilized on anionic resin, R. niveus and Amano lipase from M. 
javanicous (Table 1, entries 1-6) were inactive in kinetic resolution of rac-2-acetoxy-1-
(1H-indol-4-yloxy)-3-chloropropane (rac-4), under the above conditions. Novozym 
435, Amano PS from B. cepacia immobilized on diatomaceous earth and Amano PS 
from B. cepacia were the most active among the evaluated lipases, leading to 
conversion values near 50% in only 12 h of reaction, however with low-to-medium E-
values, ranging from 8 to 30 (Table 1, entries 13, 15-16). C. rugosa showed an 
intermediate activity, leading to 41% of conversion in 20 h, with low enantioselectivity 
(Table 1, entry 14). The best enantioselectivity (E = 79) was presented by lipase from T. 
lanuginosus, with 46% conversion after 36 h (Table 1, entry 10). In order to decrease 
the reaction time, the temperature was increased from 30 to 40 °C, showing only a slight 
acceleration from 36 h to 33 h, keeping the enantioselectivity basically unchanged 
(Table 1, entry 11). A further attempt to decrease the reaction time was performed by 
increasing the enzyme-substrate ratio from 1:1 to 2:1. Actually, the reaction time 
decreased to 24 h, however followed by a decrease in enantioselectivity with E value of 
43 (Table 1, entry 12). Lipase from P. fluorescens has provided a conversion value 
close to 50% with moderate enantioselectivity (E= 36), but in a very long reaction time, 
36 h, (Table 1, entry 7). In order to reduce the reaction time, the temperature was 
increased from 30 to 40 °C (Table 1, entry 8). In this case, besides decreasing the 
reaction time from 36 to 23 h, there was an increase in selectivity of kinetic resolution 
with E values ranging from 36 to 100 (Table 1, entry 8). It is generally assumed that 
enantioselectivity in enzyme-catalyzed reactions decreases with increasing temperature. 
However, there are several examples in the literature of enzymatic reactions in which 
enantioselectivity increases with increasing temperature [36-44]. In these situations, the 
degree of flexibility in the active site of the enzyme is more evident than the stereostatic 
and electrostatic effects among the components of the reaction, leading to a preference 
of the enantiomer favored by entropy [37,39,44]. 
  This latter result prompted us to verify if the reaction time would be decreased with a 
greater amount of enzyme. Thus, the ratio enzyme/substrate was increased from 1:1 to 
2:1 (Table 1, entry 9). However, we noticed a slight increase in the reaction time from 
23 to 25 h, but with significant increment in the enantioselectivity (E from 100 to 207), 
Table 1, entries 8 and 9. Recently, Wahab et al. reported an increase in 
enantioselectivity in the esterification of (R,S)-ibuprofen in the presence of lipase from 
the thermophilic Geobacillus zalihae with increasing enzyme loading [45]. Concerning 
the enantiopreference, all the evaluated lipases showed a marked preference for leading 
to halohydrin S-3, with the notable exception of lipase from A. niger, which produces 
the halohydrin R-3 albeit with low enantioselectivity (E value of 8; Table 1, entry 17). 
Based on the optimized conditions for systems previously studied in our research group 
[46,47], hydrolysis reactions of the rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (rac-4) were performed in the presence of THF as co-solvent. The 
enantioselectivity of the reaction underwent a dramatic increase with increasing 
temperature and enzyme:substrate ratio. However, at this stage of our investigation it 
was not clear the influence of the THF as co-solvent on the activity and selectivity of 
lipase from P. fluorescens. Therefore, we decided to investigate the effect of other co-
solvents on the efficiency of the enzymatic kinetic resolution of rac-4. In addition, the 
kinetic resolution of rac-4 was performed in the absence of co-solvents.  
3.3. Co-solvent effect on the enzymatic kinetic resolution of rac-2-acetoxy-1-(1H-indol-
4-yloxy)-3-chloropropane (rac-4) via hydrolytic process 
The study of the effect of co-solvent in the hydrolysis of rac-2-acetoxy-1-(1H-indol-4-
yloxy)-3-chloropropane (rac-4) was carried out in the presence of lipase from P. 
fluorescens, as it presented the best results of conversion and enantioselectivity (Table 
1, entry 9). Apart from THF, which was evaluated in three different ratio with respect to 
the buffering medium, hydrolysis reactions were carried out in the presence of acetone, 
acetonitrile, dioxane, isopropanol, ethanol, tert-butyl methyl ether (TBME) and hexane 
as co-solvents (buffer/co-solvent 4:1, v:v), keeping the temperature at 40 °C, ratio 
lipase/substrate 2:1 (w:w) and 25 h of reaction time. It should be noted that the 
aforementioned reaction was also performed in the absence of co-solvent. All the 
experimental data have been summarized in Table 2. 
Table 2. Co-solvent effect on the lipase from P. fluorescens-mediated enzymatic kinetic 






logP e.e.s (%)b e.e.p(%)b c(%)c Ed 
1 None - 55 73 43 11 
2 Acetone -0.24 85 84 50 31 
3 Acetonitrile -0.34 75 89 46 39 
4 Dioxane -0.27 62 88 41 29 
5 Isopropanol -0.16 50 68 42 8 
6 Ethanol -0.10 9 68 12 6 
7 THFe 0.46 97 96 50 207 
8 THFf 0.46 80 72 53 15 
9 THFg 0.46 98 95 51 180 
10 TBME 0.94 83 82 50 26 
11 Hexane 3.90 2 12 14 2 
a Conditions: 40 ºC, 25 h and lipase from P. fluorescens:rac-4 (2:1) at 250 r.p.m. 
b Determined by HPLC. 
c Conversion, c = e.e.s/(e.e.s+e.e.p). 
d Enantiomeric ratio, E = ln[1-c(1+e.e.p)]/ln[1-c(1-e.e.p)] 
e (buffer/THF 8:2, v:v) 
f (buffer/THF 9:1, v:v) 
g (buffer/THF 7:3, v:v) 
 
In the absence of co-solvent, the enantioselectivity of lipase from P. fluorescens was 
very low, with E-value of 11 (Table 2, entry 1). All evaluated co-solvents with negative 
log P values showed E-values range from low to moderate, 6-39 (Table 2, entries 2-6). 
It should be noted that protic solvents such as isopropanol and ethanol (Table 2, entries 
5 and 6) were the ones that led to the lowest values of enantioselectivity (E). Probably, 
these solvents interfere in the active enzymatic site through hydrogen bonds. On the 
other hand, when less hydrophilic THF was used as co-solvent (buffer/co-solvent 8:2, 
v:v), the enantioselectivity was greatly increased up to an E-value of 207 (Table 2, entry 
7). It should be noted that the addition of THF in proportions above or below relative to 
the aforementioned led to lower enantioselectivity (Table 2, entries 8-9). In contrast, 
solvents with increasing log P values such as TBME and hexane (Table 2, entries 10 
and 11), did not offer high enantioselectivity, most probably because of a partial loss of 
efficiency in dissolving the substrate. As far as we know, there is no general rule-
relating enhancement of enantioselectivity to the nature of the co-solvent in enzymatic 
hydrolysis reactions in monophasic aqueous systems containing a minor fraction of an 
organic solvent. A possible explanation for obtaining a high enantioselectivity value in 
the kinetic resolution of rac-4 can be performed by evoking the concept of induce-fit 
motions of the enzyme [48]. It is known that the two enantiomers of acetates from 
secondary alcohols have two different modes of attachment to the active site of a lipase. 
The large group (indole moiety) of the most reactive enantiomer (S)-4 points out from 
the active site (larger pocket) while the middle group (chlorine atom) is oriented toward 
the stereoselective pocket (smaller pocket), constituting a favorable mode. For the less 
reactive enantiomer (R)-4, the large group is positioned in the stereoselective pocket, 
while the medium group is oriented out of the active site (unfavorable mode).These 
different modes of binding the enantiomers in lipase result in the enantioselectivity 
[49,50]. It is evident that the high value of enantioselectivity obtained in the kinetic 
resolution of rac-4 in the presence of P. fluorescens is due to a combination of effects, 
which includes increasing the reaction temperature and adding an ideal amount of THF 
as the co-solvent. The addition of THF should strip off an amount of water from 
enzyme, modifying the microenvironment in the active site of the lipase. Probably, the 
new microenvironment favors a better accommodation of the indole moiety of the (S)-4 
enantiomer. The increase in temperature should be responsible for an increase in the 
conformational flexibility of the lipase and this added to the effect of the addition of 
THF should promote a more effective fitness for indole moiety of (S)-4 with the large 
binding pocket of the enzyme. These combined effects lead to better accommodation of 
the (S)-4 enantiomer at the active site and a greater stabilization of the complex between 
the substrate and enzyme. Therefore, the favorable mode should become even more 
favorable, resulting in an increase in enantioselectivity in the kinetic resolution of rac-4. 
Once that the kinetic resolution of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane 
(rac-4) was optimized for the production of enantiomerically enriched (2R)-2-acetoxy-
1-(1H-indol-4-yloxy)-3-chloropropane (R-4) (97% ee), we decided to move forward and 
explore the enzymatic acetylation of rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol 
(rac-3) mediated by P. fluorescens, in the presence of organic solvents. 
3.4. Kinetic resolution of rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) via 
acetylation reaction 
Due to the high values of conversion and enantioselectivity obtained in the hydrolysis of 
rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4) (Table 1, entry 7), 
catalysed by lipase from P. fluorescens, we selected this enzyme to mediate the kinetic 
resolution of  rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) via acetylation (Fig 
3, Path b). Based on previously reported studies, we choose the vinyl acetate as acyl 
donor [46,47]. Various solvents were evaluated at temperatures ranging between 30 and 
40 °C, (Table 3). 
Table 3. Kinetic resolution of rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3) 
via acetylation using lipase from P. fluorescens.a 















30 2 >99 2 >200 
2 40 4 91 4 22 
3 Heptane 24 30 13 88 13 18 
4 Toluene 24 30 15 75 17 8 
5 Cyclohexane 24 30 20 53 27 4 





30 21 91 19 26 





24 84 22 14 











9 94 9 35 
12 68 23 94 20 40 




11 >99 10 >200 
14 48 13 >99 11 >200 
15 72 14 >99 12 >200 
16 120 14 >99 12 >200 
17 24 40 
40 
15 >99 13 >200 
18 48 26 94 22 42 
aConditions: lipase from P. fluorescens:rac-3 (1:1), vinyl acetate as acyl donor (5 eq.)  in organic solvent, 
at 250 r.p.m. 
b Determined by HPLC. 
c Conversion, c = e.e.s/(e.e.s+e.e.p). 
d Enantiomeric ratio, E = ln[1-c(1+e.e.p)]/ln[1-c(1-e.e.p)] 
e (10 eq. of vinyl acetate) 
 
As THF was successfully used as co-solvent in the hydrolysis of rac-2-acetoxy-1-(1H-
indol-4-yloxy)-3-chloropropane (rac-4), it was the first solvent evaluated in acetylation 
of rac-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (rac-3), in the presence of lipase from 
P. fluorescens. However, THF decreases the enzymatic activity leading to a conversion 
of only 2%, while the selectivity remained high, E-value > 200 (Table 3, entry 1). With 
increasing temperature of 30 to 40 °C, the enzyme activity showed only a slight increase 
to 4% of conversion, with a decrease of E-value to 22, (Table 3, entry 2). In more 
hydrophobic solvents (i.e., heptane, toluene, cyclohexane and hexane), conversion 
values range from low to moderate (13-31%), but with quite low enantioselectivity 
(Table 3, entries 3-6). When the acetylation was carried out in the presence of TBME as 
solvent, the corresponding acetate (S-4) was obtained with e.e. of 91%, but the 
conversion value was only 19% (Table 3, entry 7). This result encouraged us to provide 
conditions to achieve a conversion close to 50% with still high enantioselectivity. 
Firstly, temperature was increased from 30 to 40 °C, leading a desired conversion value 
(51%). However, the selectivity decreased dramatically, with E-value of only 11 (Table 
3, entry 8). More attempts to optimize reaction conditions in the presence of TBME 
were performed; the amount of vinyl acetate was doubled from 5 to 10 equivalents and 
the reaction time prolonged from 24 to 68 h, but the selectivity of the reaction remained 
low, with E-value of only 14, (Table 3, entries 9-10). In acetonitrile and reaction time of 
24 h, the acetylated product (S-4) was obtained with a high value e.e. (94%), but low 
conversion value, only 9% (Table 3, entry 11). By increasing the reaction time from 24 
to 68 h, conversion increased from 9 to 20% while maintaining high e.e. (94%) of the 
product, (Table 3, entry 12). To decrease reaction time, we decided to increase the 
temperature from 30 to 35 °C. Thus, in 24 h, the acetylated product (S-4) was obtained 
with high selectivity (99% e.e.) and E-value > 200, but with conversion of 10% (Table 
3, entry 13). In order to achieve 50% conversion, reaction was monitored up to 120 h, 
but the conversion remained practically unaltered (Table 3, entries 14-16). An increase 
of 5 °C in the temperature (40 °C) led to only a slight increase in the conversion of 10 to 
13%, while maintaining the high e.e. (>99%) to (S-4) (Table 3, entry 17). A higher 
reaction time (48 h) afforded a higher conversion value (22%), but with a decrease in 
e.e. (94%) to (S-4) (Table 3, entry 18).  
These results were not so promising when compared with the hydrolytic process. This 
prompted us to move our attention to further optimize the performance of the hydrolysis 
process. In the kinetic resolution of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (rac-4), the compound with the desired configuration is the remaining 
substrate (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (R-4). Then, the latter 
should be subjected to a hydrolysis reaction to get the key intermediate in the synthesis 
of (S)-Pindolol (S-5), the haloydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-
3). To catalyze this hydrolysis, we choose the lipase from C. rugosa, which proved to be 
active, but not selective (Table 1, entry 14).  
 
3.5. Synthesis of the key intermediate haloydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-
propanol (R-3) 
 
Once obtained the (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (R-4) 
enantiomerically enriched (97% e.e.), we turn our attention to the preparation of the 
halohydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3), the key intermediate 
in the synthesis of (S)-Pindolol (S-5). The hydrolysis of (2R)-2-acetoxy-1-(1H-indol-4-
yloxy)-3-chloropropane (R-4) (97% e.e.), mediated by lipase from C. rugosa in 
phosphate buffer (pH 7)/THF (4:1, v:v) at 40 °C for 12 h, led to (2R)-1-(1H-indol-4-
yloxy)-3-chloro-2-propanol (R-3) (97% e.e.) in quantitative yield.  
 
3.6. Synthesis of (S)-Pindolol 
Finally, the haloydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-propanol (R-3) was 
subjected to reaction with excess of isopropylamine, under reflux, leading to (S)-
Pindolol (S-5) (97% e.e.), in a quantitative yield. 
 
4. Conclusion 
In summary, we have prepared the (S)-Pindolol based on a chemoenzymatic process 
using lipases. Lipase from P. fluorescens proved to be a robust catalyst in the kinetic 
resolution of rac-2-acetoxy-1-(1H-indol-4-yloxy)-3-chloropropane (rac-4), via 
hydrolysis reaction, leading to the intermediate (2R)-2-acetoxy-1-(1H-indol-4-yloxy)-3-
chloropropane (R-4) with 97% ee. It is noteworthy that the kinetic resolution through 
the hydrolytic process was efficient when the THF was used as co-solvent and when the 
reaction temperature was increased from 30 to 40 °C, resulting in high 
enantioselectivity (E >200). A particular behavior of the high enantioselectivity induced 
by a higher reaction temperature and the addition of an ideal amount of THF as a co-
solvent can be explained by a model in which stabilization of the association between 
the correctly binding enantiomer and the lipase active site was increased by the great 
conformational flexibility of the lipase. Therefore, parameters such as temperature and 
addition of an appropriate co-solvent are ways of tuning the enantioselectivity of an 
enzyme. Lipase from C. rugosa was efficient in the hydrolysis of the chiral acetate 
yielding as key intermediate the halohydrin (2R)-1-(1H-indol-4-yloxy)-3-chloro-2-
propanol (R-3) with 97% ee in quantitative yield. The kinetic resolution was more 
efficient in the hydrolytic process rather than acylation process in organic solvent.  
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